Shoulder Innovations in Grand Rapids, founded in 2009 by Dr. Steve Gunther, completed a $75 million IPO on July 31, offering 5 million shares at $15 per share. The company is trading on the NYSE under the ticker symbol SI.
On Sept. 22, the company announced the full commercial launch of the InSet 70 Humeral Stem. The introduction of the InSet 70 represents an expansion of the company’s I-Series humeral stem product line, which first launched with the InSet 95 humeral stem in 2024.
“The InSet 70 complements our broad portfolio of advanced shoulder implant solutions, and we are excited to bring it to market across the United States ahead of schedule,” says Rob Ball, CEO of Shoulder Innovations. “SI has a strong history of innovation, and the InSet 70 is another example of new technology designed to enhance the quality of care for patients and provide meaningful value to the surgeons who care for them. We look forward to seeing improved patient outcomes and long-term function with this implant.”
Indicated for use in both anatomic and reverse shoulder arthroplasty, the InSet 70 is designed to address a broad range of clinical needs, including non-inflammatory degenerative joint disease such as osteoarthritis and avascular necrosis, rheumatoid and traumatic arthritis, and correction of functional deformity. In reverse procedures, it is further indicated for irreparable cuff tears with or without arthritis, as well as for revision of other devices when sufficient bone stock remains.
Name: Shoulder Innovations
Address: 1535 Steele Ave. SW, Grand Rapids
Email: info@shoulderinnovations.com
Website: shoulderinnovations.com
Phone Number: 616-294-1026
Category: Medical
Founded: 2009
Founder: Dr. Steve Gunther
Number of Employees: 56
Most Recent Annual Revenue: $31.62 million
Video Link: Visit here.
DISCLAIMER: DBusiness and its parent company Hour Media, L.L.C. and each of their respective affiliates, employees, members, officers, directors, and contractors, are not registered brokers or dealers in securities or investment advisers. Content published or distributed by DBusiness regarding any company or business, whether by paper hard copy or by electronic internet distribution, is based on information provided to us without verification and is intended for informational purposes only. The content on this site is not an offer to sell or buy, or a solicitation of an offer to sell or buy securities, and does not constitute investment advice or a recommendation to invest or an endorsement of any company or business or a basis for making any investment decision.
